Thymosin Alpha-1
Injectable

Immune & Wellness

A thymic peptide studied in immune-regulation research

01

Thymic peptide studied in research on immune regulation

02

Research describes its role in T-cell maturation and CD4+/CD8+ balance

03

Investigated for activation of dendritic cells via TLR2/TLR9 signaling

Immune & Wellness

Thymosin Alpha-1

Thymosin Alpha-1 is a thymic peptide studied in research for its role in T-cell maturation, dendritic cell activation, and immune signaling.

25mg vial · 5mg/mL · 5mL99.2% purity

Choose your plan

Peptide checkout

1. Purchase type

2. Choose billing term

How this plan works

Pay

$618.30 today

Renews every 3 months

Ship

Every 3 months

After provider approval

Refills

Paid quarterly

Continues until canceled

Continue with 3-month plan → $618.30
Peptide checkout
Provider review
Ships after approval

A U.S.-licensed provider reviews your request before it ships. If you are not approved, you are refunded in full.

Quick answer

Thymosin Alpha-1 is a thymic peptide studied in research for its role in T-cell maturation, dendritic cell activation, and immune signaling.

Format

Injectable

Best use

Immune & Wellness

Evidence

Research-framed

503A Pharmacy
USP <797> Sterile
Provider-Reviewed
Lab-Tested
Cold-Chain
HIPAA

Deep research

About Thymosin Alpha-1

Thymosin Alpha-1 (Ta1) is a 28-amino-acid peptide (MW ~3,108 Da) with an acetylated N-terminal serine, a modification important for biological activity. Ta1 is naturally produced by thymic epithelial cells and was first isolated and characterized by Allan Goldstein at George Washington University in the 1970s from the thymic fraction known as Thymosin Fraction 5. The thymus is the central organ of T-cell development, and it undergoes progressive involution with age, a process studied in relation to immunosenescence.

Lyophilized Ta1 is stored refrigerated at 2-8C and is stable for extended periods. Reconstituted solutions are refrigerated and the peptide is stable at pH 5.0-7.5. Given its 28-residue length, Ta1 is more sensitive to physical aggregation than smaller peptides, so gentle swirling rather than vigorous shaking is recommended during reconstitution.

Key benefits

What researchers have looked at

1

Thymic peptide studied in research on immune regulation

2

Research describes its role in T-cell maturation and CD4+/CD8+ balance

3

Investigated for activation of dendritic cells via TLR2/TLR9 signaling

4

Studied for bidirectional immune modulation in the literature

5

Examined in research on regulatory T-cell (Treg) activity

6

First isolated and characterized by Allan Goldstein at GWU in the 1970s

7

Studied as an immune adjuvant in multiple clinical research settings

8

Decades of published research and a well-documented tolerability profile

Mechanism

How Thymosin Alpha-1 is positioned in research

Research describes Ta1 interacting with Toll-like receptors (TLR2, TLR9) on dendritic cells, associated with enhanced antigen presentation and upregulation of MHC class I/II and co-stimulatory molecules (CD80, CD86). The literature characterizes Ta1 as modulating rather than simply stimulating immune function, with reported effects on CD4+/CD8+ T-cell populations and regulatory T-cell (Treg) activity. Plasma half-life is approximately 2 hours after subcutaneous administration.

Published research

What the research has explored

Ta1 has been studied in clinical research as an immune adjuvant. Reported work includes a meta-analysis of randomized controlled trials in chronic hepatitis B (J Viral Hepatitis, 2004) and retrospective COVID-19 studies (e.g., Liu et al., Clin Infect Dis, 2020). Across decades of clinical use, the tolerability profile is well documented, with reported effects limited to occasional mild injection site reactions and transient low-grade fever.

For research and educational purposes only. References to studies describe published literature and do not constitute medical claims, efficacy guarantees, or treatment recommendations.

Questions people ask

Frequently asked questions

What is Thymosin Alpha-1?+

Thymosin Alpha-1 is a 28-amino-acid acetylated thymic peptide (MW ~3,108 Da) first characterized by Allan Goldstein in the 1970s. It is studied in research on immune regulation.

How does it interact with the immune system?+

Research describes activation of TLR2/TLR9 on dendritic cells and modulation of T-cell populations and regulatory T-cells, characterized as bidirectional immune modulation.

How is it handled?+

Lyophilized Ta1 is stored at 2-8C and reconstituted gently to avoid aggregation, given its longer 28-residue chain.

Concentration

5mg/mL · 5mL

Purity

99.2%

Format

Injectable

Vial

25mg vial

Compare next

Related peptides